Amgen (AMGN) Operating Expenses (2009 - 2026)

Amgen has reported Operating Expenses for 18 years, with the latest figure at $6.5 billion in Q2 2026.

• On a quarterly basis, Operating Expenses changed 0.26% year-over-year to $6.5 billion in Q2 2026; TTM through Jun 2026 was $26.7 billion, a 0.21% change from a year earlier, with the FY2025 full-year figure at $27.7 billion, up 5.75% from the prior year.
• Operating Expenses was $6.5 billion for Q2 2026 at Amgen, up from $6.0 billion in the prior quarter.
• The five-year high for Operating Expenses was $7.1 billion in Q4 2025, with the low at $3.7 billion in Q1 2022.
• Average Operating Expenses over 5 years is $5.7 billion, with a median of $6.5 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses decreased 22.46% in 2022, then jumped 54.3% in 2024.
• Over 5 years, Operating Expenses stood at $4.6 billion in 2022, then surged by 50.25% to $6.9 billion in 2023, then dropped by 2.17% to $6.8 billion in 2024, then increased by 5.48% to $7.1 billion in 2025, then decreased by 8.48% to $6.5 billion in 2026.
• The last three Operating Expenses figures came in at $6.5 billion (Q2 2026), $6.0 billion (Q1 2026), and $7.1 billion (Q4 2025), per Business Quant data.